Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Simple blood test may forecast heart risks after bypass surgery

NCT ID NCT07480915

First seen Apr 01, 2026 · Last updated May 24, 2026 · Updated 7 times

Summary

This study looks at 160 people with heart failure who are scheduled for coronary artery bypass surgery. Researchers want to see if a substance in the blood called GDF-15 can help predict serious heart problems, like heart attacks or hospital stays, in the year after surgery. Participants will have their blood tested before surgery and be followed for 12 months to track their health.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cardiology Research Institute, Tomsk National Research Medical Center Russian Academy of Sciences

    RECRUITING

    Tomsk, Tomsk Oblast, 634050, Russia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.